Ryan Izzo
Tight End
Age: 27
Free Agency: 2023 (UFA)
Accrued Seasons: 4
- Height: 6'5"
- Weight: 245
- College: Florida State
- Entry: 2018 Draft, Round 7, #250 overall (Patriots)
- 2022 Salary Cap Charge: $895,000 (0.42% of cap)
- 2022 Cash Payout: $895,000 (0.37% of spending)
- 2022 Cash to Cap Ratio: 1.00
- Contract Value: $1,745,000 ($872,500 APY)
- Fully Guaranteed Money: $0
- Contract Ranking: 114/200 at TE
Current Contract
(SFA, signed 2021)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Cap Number | Cap % | Dead Money & Cap Savings | |||
|---|---|---|---|---|---|---|---|---|
| 2021 | 26 | $850,000 | $47,222 | 0.0% | ||||
| 2022 | 27 | $895,000 | $895,000 | 0.4% | ||||
| Total | $1,745,000 | $942,222 | ||||||
Contract Notes
Ryan Izzo signed a four year contract with the New England Patriots worth $2,529,072 on May 10, 2018. Izzo received a $69,072 signing bonus. Izzo was the 250th pick in the 2018 NFL Draft.
Cash Flows
| Old Money | 2021 | 2022 | |
|---|---|---|---|
| Cash Due | $802,778 | $47,222 | $895,000 |
| Running Cash | $850,000 | $1,745,000 |
Career Earnings: $1,873,294
Career APY: $468,324
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Texans | Drafted | Terminated | 2018 | 4 | $2,529,072 | $632,268 | $69,072 | $0 | 0.0% | $0 |
| Patriots | Drafted | Traded | 2018 | 4 | $2,529,072 | $632,268 | $69,072 | $1,602,072 | 63.3% | $534,024 |
| Giants | Practice | Terminated | 2021 | 1 | $252,000 | $252,000 | $0 | $0 | 0.0% | $0 |
| Seahawks | Practice | Terminated | 2021 | 1 | $252,000 | $252,000 | $0 | $0 | 0.0% | $0 |
| Titans | SFA | Active | 2021 | 2 | $1,745,000 | $872,500 | $0 | $47,222 | 2.7% | $47,222 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Texans | 0 | $0 | $0 | $0 | 0.0% | $0 | 0.0% |
| Patriots | 3 | $1,602,072 | $534,024 | $1,584,804 | 0.0% | $17,268 | 0.0% |
| Giants | 0 | $28,000 | $0 | $0 | 0.0% | $28,000 | 0.0% |
| Seahawks | 0 | $196,000 | $0 | $0 | 0.0% | $196,000 | 0.0% |
| Titans | 1 | $47,222 | $47,222 | $47,222 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Cap Number | Cap % | Cash Paid | |
|---|---|---|---|---|---|---|---|
| 2018 | Patriots | $480,000 | $17,268 | $380,268 | 0.2% | $432,072 | |
| 2019 | Patriots | $495,000 | $17,268 | $512,268 | 0.3% | $495,000 | |
| 2020 | Patriots | $675,000 | $17,268 | $692,268 | 0.3% | $675,000 | |
| 2021 | Titans | $850,000 | $0 | $47,222 | 0.0% | $47,222 | |
| 2022 | Titans | $895,000 | $0 | $895,000 | 0.4% | $895,000 | |
| Total | $3,395,000 | $51,804 | $2,527,026 | $2,544,294 | |||
Statistics
| Year | Games Played | Games Inactive | Snaps | Rushing | Receiving | Fumbles | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injured | Healthy | Offense | Special | Att | Yards | Avg | TD | Rec | Yards | Avg | TD | Total | Lost | ||
| 2019 | 6 | 3 | 6 | 23.4% | 0.9% | 0 | 0 | 0.0 | 0 | 6 | 114 | 19.0 | 1 | 0 | 0 |
| 2020 | 12 | 0 | 0 | 61.9% | 1.0% | 0 | 0 | 0.0 | 0 | 13 | 199 | 15.3 | 0 | 0 | 0 |
| 2021 | 1 | 0 | 0 | 0.4% | 0.0% | 0 | 0 | 0.0 | 0 | 0 | 0 | 0.0 | 0 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $286,000 | $872,500 |
| Injury Adjusted | $286,000 | $872,500 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.